![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 3, 1443-1449, January 17, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Molecular Cell Biology, The Weizmann
Institute of Science, Rehovot 76100, Israel
Exposure of cells to genotoxic agents results in
activation of checkpoint pathways leading to cell cycle arrest. These
arrest pathways allow repair of damaged DNA before its replication and segregation, thus preventing accumulation of mutations. The tumor suppressor retinoblastoma (RB) is required for the
G1/S checkpoint function. In addition, regulation of
the G2 checkpoint by the tumor suppressor p53 is
RB-dependent. However, the molecular mechanism underlying
the involvement of RB and its related proteins p107 and p130 in the
G2 checkpoint is not fully understood. We show here that
sustained G2/M arrest induced by the genotoxic agent doxorubicin is E2F-dependent and involves a decrease in
expression of two mitotic regulators, Stathmin and AIM-1. Abrogation of
E2F function by dominant negative E2F abolishes the doxorubicin-induced down-regulation of Stathmin and AIM-1 and leads to premature exit from
G2. Expression of the E7 papilloma virus protein, which
dissociates complexes containing E2F and RB family members, also
prevents the down-regulation of these mitotic genes and leads to
premature exit from G2 after genotoxic stress. Furthermore,
genotoxic stress increases the levels of nuclear E2F-4 and p130 as well
as their in vivo binding to the Stathmin promoter. Thus,
functional complexes containing E2F and RB family members appear to be
essential for repressing expression of critical mitotic regulators and
maintaining the G2/M checkpoint.
Incumbent of the Recanati Career Development chair of cancer
research. To whom correspondence should be addressed: Dept. of Molecular Cell Biology, The Weizmann Inst. of Science, Rehovot 76100, Israel. Tel.: 972-8-934-2239; Fax: 972-8-934-4125; E-mail: doron. ginsberg{at}weizmann.ac.il.
This article has been cited by other articles:
![]() |
K. B. Spurgers, D. L. Gold, K. R. Coombes, N. L. Bohnenstiehl, B. Mullins, R. E. Meyn, C. J. Logothetis, and T. J. McDonnell Identification of Cell Cycle Regulatory Genes as Principal Targets of p53-mediated Transcriptional Repression J. Biol. Chem., September 1, 2006; 281(35): 25134 - 25142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Jackson, M. K. Agarwal, J. Yang, P. Bruss, T. Uchiumi, M. L. Agarwal, G. R. Stark, and W. R. Taylor, p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2 J. Cell Sci., May 1, 2005; 118(9): 1821 - 1832. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Douglas, R. Farahani, P. Morcillo, A. Kanaan, T. Xu, and G. G. Haddad Hypoxia induces major effects on cell cycle kinetics and protein expression in Drosophila melanogaster embryos Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R511 - R521. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |